SDIX and BD Partner to Develop Microbiology Detection System
09 Feb 2012

SDIX and BD Diagnostics, have announced an agreement to develop a microbiology detection system. SDIX, is a biotechnology company which specializes in providing and improving antibodies, antigens and assays. The collaboration will combine SDIX’s expertise in development of high performance antibodies, with BD’s expertise in diagnostic system development.

Under the terms of the agreement, SDIX will provide BD Diagnostics access to its proven antibody technology and a non-exclusive license to its patented bacteria phage technology. Following commercialization of the system, SDIX and BD will be engaged in a long term agreement for the supply of antibodies from SDIX to BD.

Francis DiNuzzo, SDIX’s President and CEO commented, “We are excited to be working with a world class organization like BD. This agreement demonstrates our strengths in the design and production of novel, highly specific antibodies and our knowledge and experience in developing antibody based detection systems.” Mr. DiNuzzo went on to say, “The combination of SDIX’s antibodies together with the assay and platform capabilities of BD will enable the partnership to deliver a highly valuable system that we expect to advance microbial detection in many very valuable applications. We are pleased with the opportunity to collaborate with such a capable and well known organization.”

Request Info


Company website

SDIX
profile photo

Sonia Nicholas
Clinical Diagnostics Editor